In view of our previous observation that blockade of ubiquitination on TRAF6 by DRAK1 was a key mechanism regulating TRAF6 stability in cervical cancer cells [12], targeting TRAF6 E3 ligase activity associated with drug resistance in other cancers deserve further investigation. Here, STK17A is linked to cervical carcinoma.